Press release
Bunion Market to Experience Growth by 2034, DelveInsight | Companies involved Syntellix, Treace Medical Concepts, Wright Medical Technology, Trilliant Surgical, Arthrosurface, Nextremity Solutions, Wr
Bunion Market to Experience Growth
Emerging bunion therapies, including Magnezix CS and Lapiplasty 3-Dimensional Bunion Correction, are poised to boost market growth by providing innovative, minimally invasive solutions that enhance patient outcomes and accelerate recovery. Along with rising awareness, increasing prevalence-particularly among women, and growing demand for effective surgical and non-surgical options, these advancements are expected to drive the bunion market forward in the coming years.
DelveInsight has launched a new report on "Bunion - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Bunion, historical and forecasted epidemiology as well as the bunion market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Request for a detailed bunion market sample report @ https://www.delveinsight.com/report-store/bunion-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Some of the key facts of the Bunion Market Report:
*
According to DelveInsight, there were approximately 190 million prevalent cases of hallux valgus in the 7MM in 2023, with the United States accounting for the largest share of the bunion treatment market. In the US alone, there were about 100 million mild cases, 40 million moderate cases, and 10 million severe cases, with females 2-3 times more likely than males to be affected.
*
The current bunion treatment pipeline is limited, with most emerging therapies, such as PRF-110 and CPL-01, primarily focusing on symptom relief rather than addressing the underlying deformity.
*
In regulatory developments, DePuy Synthes (Johnson & Johnson) received FDA 510(k) clearance for its TriLEAP Trademark Lower Extremity Anatomic Plating System, a modular platform designed for foot and ankle procedures, including bunionectomies, expected to launch in the US in 2024. Additionally, in August 2024, PainReform reported progress in identifying the optimal delivery method for PRF-110 in bunionectomy procedures, positioning it as a promising option for post-surgical pain management.
*
Key companies advancing the bunion treatment landscape include Syntellix, Treace Medical Concepts, Wright Medical Technology, Trilliant Surgical, Arthrosurface, Nextremity Solutions, among others. Prominent pipeline candidates under development include CPL-01, PRF-110, and additional therapies aimed at improving outcomes for bunion patients.
Key benefits of the Bunion market report:
*
The bunion market report covers a descriptive overview and comprehensive insights into the Bunion Epidemiology and market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan).
*
The Bunion market report provides insights into the current and emerging therapies.
*
The Bunion market report provides a global historical and forecasted market covering drug outreach in 7MM.
*
The Bunion market report offers an edge that helps in developing business strategies by understanding the trends shaping and driving the Bunion market.
Got queries? Click here to know more about the bunion market landscape https://www.delveinsight.com/sample-request/bunion-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Bunion Overview
Hallux valgus, commonly known as a bunion, is a prevalent foot deformity in which the big toe deviates outward at the first metatarsophalangeal joint, creating a prominent bony bump along the inner side of the foot. The condition arises from a combination of genetic factors, anatomical variations, and environmental influences, such as wearing tight or high-heeled shoes, which can exacerbate the deformity. The lateral displacement of the first metatarsal and rotation of the big toe often leads to pain during walking or weight-bearing activities.
Diagnosis is primarily clinical, based on a thorough physical examination and patient history. Common symptoms include pain, swelling, and redness over the bunion, often worsened by constrictive footwear. Clinicians evaluate toe alignment and associated complications like calluses or bursitis. X-rays are used to confirm the diagnosis and determine deformity severity by measuring the hallux valgus angle (HVA) and intermetatarsal angle (IMA). An HVA greater than 15 degrees indicates hallux valgus, with severity classified as mild, moderate, or severe.
Bunion Market Outlook
Leading companies in the bunion treatment sector-such as Concentric Analgesics, Pacira Pharmaceuticals, Cali Pharmaceuticals, and PainReform-are actively progressing their key drug candidates through various stages of clinical development, aiming to evaluate their potential for managing bunions.
In 2023, conservative management accounted for roughly 40% of the 7MM bunion market revenue, while bunionectomy remained the dominant approach, capturing about 60%. Among the EU4 and the UK, Germany led in revenue with approximately USD 700 million, and France contributed around 20% of the market share within that region.
Explore how the bunion market is rising in the upcoming years @ https://www.delveinsight.com/report-store/bunion-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Bunion Marketed Drugs
*
Magnezix CS: Syntellix
*
Lapiplasty 3-Dimensional Bunion Correction: Treace Medical Concepts
*
PROstep Minimally Invasive Surgery System: Stryker
Bunion Emerging Drugs
*
CPL-01: Cali Pharmaceuticals
*
PRF-110: PainReform
To know more about the therapies that are driving the Bunion treatment market, visit: https://www.delveinsight.com/sample-request/bunion-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Scope of the Bunion Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Bunion Companies: Syntellix, Treace Medical Concepts, Wright Medical Technology, Trilliant Surgical, Arthrosurface, Nextremity Solutions, Wright medical, and others
*
Key Bunion Therapies: CPL-01, PRF-110, and others.
*
Bunion Therapeutic Assessment: Bunion current marketed and bunion emerging therapies
*
Bunion Market Dynamics: Bunion market drivers and bunion market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Bunion Unmet Needs, KOL's views, Analyst's views, Bunion Market Access and Reimbursement
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Bunion Patient Share (%) Overview at a Glance
5. Bunion Market Overview at a Glance
6. Bunion Disease Background and Overview
7. Bunion Epidemiology and Patient Population
8. Country-Specific Patient Population of Bunion
9. Bunion Current Treatment and Medical Practices
10. Unmet Needs
11. Bunion Emerging Therapies
12. Bunion Market Outlook
13. Country-Wise Bunion Market Analysis (2020-2034)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Bunion Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about bunion Market Outlook 2034 @ https://www.delveinsight.com/report-store/bunion-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Related Reports:
Bunion Pipeline Insights, DelveInsight
"Bunion Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Bunion market. A detailed picture of the Bunion pipeline landscape is provided, including a disease overview and treatment guidelines for Bunion.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=bunion-market-to-experience-growth-by-2034-delveinsight-companies-involved-syntellix-treace-medical-concepts-wright-medical-technology-trilliant-surgical-arthrosurface-nextremity-solutions-wr]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bunion Market to Experience Growth by 2034, DelveInsight | Companies involved Syntellix, Treace Medical Concepts, Wright Medical Technology, Trilliant Surgical, Arthrosurface, Nextremity Solutions, Wr here
News-ID: 4170792 • Views: …
More Releases from ABNewswire
PI3K Inhibitors Market Outlook: Roche, Novartis, and Emerging Biotechs Drive Com …
DelveInsight's comprehensive analysis reveals robust growth potential in the PI3K inhibitors market across 7MM through 2034. Key players include Roche/Genentech (ITOVEBI), Novartis (PIQRAY), Gilead Sciences (ZYDELIG), Kazia Therapeutics (Paxalisib), Celcuity (Gedatolisib), and others, with expanding applications from hematological to solid tumor indications driving market momentum.
PI3K Inhibitor Key Takeaways
*
PI3K Inhibitor market size projection: As per DelveInsight's analysis, the total market size of PI3K inhibitors in the 7MM is expected to…
PDE4 Inhibitors Market Growth Accelerates Amid FDA Approvals, Pipeline Expansion …
DelveInsight's PDE4 Inhibitor Market Report Reveals Significant Growth Through 2034, Led by Arcutis Biotherapeutics, Pfizer, Shionogi, Palisade Bio, UNION Therapeutics, Amgen, and Chiesi Farmaceutici with Key Assets Including ZORYVE, EUCRISA, OTEZLA, Zatolmilast, and PALI-2108 Across Multiple Inflammatory Conditions.
DelveInsight Business Research's extensive market analysis titled "Phosphodiesterase-4 (PDE4) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 [https://www.delveinsight.com/report-store/phosphodiesterase-4-pde4-inhibitor-market-forecast?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]," provides a comprehensive insights into this rapidly evolving therapeutic class across…
PD-L1 Inhibitors Market Dynamics: Robust Pipeline, Regulatory Wins, and Competit …
DelveInsight's PD-L1 Inhibitors Market Analysis reveals $36B market across 7MM, dominated by Merck's KEYTRUDA and BMS's OPDIVO. Key players include Genentech, AstraZeneca, Regeneron, Pfizer. Emerging pipeline features sasanlimab, HLX43, balstilimab. Patent expirations in 2028 expected to reshape competitive landscape with biosimilar entry anticipated.
PD-L1 Inhibitors Market Key Takeaways
*
Market size projection: As per DelveInsight's analysis, the total market size of PD-L1 inhibitors in the 7MM is expected to surge significantly from…
Cataplexy Pipeline Analysis, 2025 by DelveInsight | Avadel, Axome Therapeutics
DelveInsight's, "Cataplexy - Pipeline Insight, 2025," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Cataplexy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
According to DelveInsight, over three key companies are actively advancing more than…
More Releases for Bunion
4D Advanced Bunion Correction: Revolutionary Approach for Pain-Free Mobility.
The world of podiatry takes a significant leap forward with the introduction of the 4D Advanced Bunion Correction, a revolutionary surgical technique that promises pain-free mobility and a faster recovery for individuals suffering from bunions. This state-of-the-art procedure combines advanced technology with minimally invasive methods to offer patients a new lease on life.
Traditional bunion surgeries often involve long recovery periods, significant pain, and a higher risk of recurrence. However, the…
Bunion Splint Market 2024: A Decade of Phenomenal Growth Ahead
The Bunion Splint Market 2024-2023 report provides a comprehensive analysis of Types (Plastic, Nylon), Application (Hospital, Clinic), Analysis of Industry Trends, Growth, and Opportunities, R&D landscape, Data security and privacy concerns Risk Analysis, Pipeline Products, Assumptions, Research Timelines, Secondary Research and Primary Research, Key Insights from Industry Experts, Regional Outlook and Forecast, 2024-2032.
Major Players of Bunion Splint Market are:
Breg, Medical Brace, Fresco, Novamed, Algeos, Blunding, Bauerfeind, Dr. Med, 3-Point Products, Santemol…
Nagler Foot Center: Providing Trusted Hammertoe and Bunion Treatment Services
Nagler Foot Center, a dedicated podiatric center, provides hammertoe surgery and bunion treatment in Houston.
Foot injuries are bound to happen when much exertion or stress occurs on the feet. However, with the help of competent foot doctors, people can get quality treatment for their foot injuries. Nagler Foot Center is a dedicated clinic focused on treating several foot deformities. Dr. Sherman Nagler, a distinguished and solution-focused foot doctor in Houston,…
Nagler Foot Center: Providing Standard Bunion and Achilles Tendon Treatment
Nagler Foot Center, a leading podiatric center, provides highly effective bunion treatment and Achilles tendon repair services in Houston, TX.
When people experience problems with their feet, it can make them less efficient at doing things they love to do, especially athletes. However, with the help of qualified and reliable foot doctors, they can get back to full form in no time. Nagler Foot Center is a solution-focused foot clinic that…
4D Advanced Bunion Correction: Revolutionary Approach for Pain-Free Mobility
Discover the latest breakthrough in bunion treatment with 4D Advanced Bunion Correction. This state-of-the-art procedure offers a minimally invasive solution to realign the bones and joints, reducing pain and enhancing mobility. Utilizing advanced imaging technology, our skilled surgeons tailor the surgery to your unique anatomy, ensuring optimal outcomes and quicker recovery times. Say goodbye to the discomfort of traditional bunion surgery and step into a future of pain-free walking with…
Minilock in Bunion Surgery: A Revolutionary Approach
Bunions, medically known as hallux valgus, are a common foot deformity that affects millions of people worldwide. This condition is characterized by a misalignment of the big toe, which often causes pain, swelling, and difficulty in wearing shoes. Traditional surgical methods for correcting bunions can be invasive, with long recovery times. However, a new technique involving Minilock technology is gaining attention for its potential to improve surgical outcomes and reduce…
